SARAH JOHNSON

Sarah Johnson has extensive experience in the pharmaceutical industry. SARAH most recently worked as a Critical Care Specialist at Innoviva Specialty Therapeutics, Inc. starting in September 2021. Prior to that, Sarah served as an Executive Institutional Representative at Merck from April 2016 to September 2021. SARAH also worked at Theravance as an Institutional Account Manager from October 2014 to August 2015. Sarah's earlier roles include Executive Hospital Specialist at Merck from August 2008 to October 2014, Cardiovascular Account Specialist at CV Therapeutics from January 2008 to August 2008, and Executive Hospital Sales Specialist at Elan Pharmaceuticals from March 2004 to September 2007. SARAH also worked at Pfizer as a Senior Institutional Sales Consultant from May 2002 to July 2003, and at Elan Pharmaceuticals as an Executive Hospital Sales Specialist from November 2000 to May 2002. Sarah began their career in the pharmaceutical industry as a Senior Hospital Infectious Disease Specialist at sanofi-aventis from April 1999 to November 2000, and as a Hospital Sales Representative at AstraZeneca from July 1997 to April 1999.

Sarah Johnson attended the University of East Anglia from 1985 to 1989, where they obtained a degree in Registered Nursing/Registered Nurse (RN).